Skip to main content
eScholarship
Open Access Publications from the University of California

School of Medicine

Department of Surgery - Open Access Policy Deposits bannerUC San Diego

This series is automatically populated with publications deposited by UC San Diego School of Medicine Department of Surgery researchers in accordance with the University of California’s open access policies. For more information see Open Access Policy Deposits and the UC Publication Management System.

Cover page of Factors Associated With 30-Day Readmission in Hand Surgery Patients.

Factors Associated With 30-Day Readmission in Hand Surgery Patients.

(2025)

Background

Surgical patient hospital readmissions are costly to the health care system. The Affordable Care Act Hospital Readmissions Reduction Program introduced penalties for high hospital readmission rates. We performed a retrospective study evaluating factors associated with readmission in hand surgical inpatients.

Methods

We performed a retrospective chart review on 566 patients admitted to a level 1 trauma center for hand trauma or infection from January 1, 2016, to December 31, 2019. Data included demographics, social history, medical problems, comorbidities, procedure details, and admission and readmission details. A multivariable regression analysis was performed to identify factors associated with hospital readmission within 30 days.

Results

Cigarette smoking (P = .048), bite wound (P = .038), laceration wound (P = .028), laceration repair (P < .01), open reduction internal fixation (P = .041), and disposition to a skilled nursing facility (P = .017) were significantly associated with readmission to the hospital within 30 days. For patients who underwent emergency department interventions, alcohol use (P = .034), houselessness (P = .046), and malnutrition (P = .036) were additional factors associated with readmission.

Conclusions

Immediately irremediable factors such as tobacco and alcohol abuse, malnutrition, and houselessness should be considered as exemptions for penalties levied on health care systems for readmissions. Initiating targeted interventions, such as detoxification, smoking cessation, housing assistance, and improved nutrition, may reduce readmission risk and could improve patient outcomes.

Cover page of Fluid Flow Measurements in Nanoslits Using Holographic Microscopy

Fluid Flow Measurements in Nanoslits Using Holographic Microscopy

(2025)

To understand the mechanisms driving fluid flow behavior in nanofluidics so that they may be used for on-chip biomedical and chemical applications, the fluid's motion itself needs to be observable and measurable, a difficult challenge at these small scales. We present a new method for measuring both slow and fast flows in nanofluidics using high-speed digital holographic microscopy. We measure the evaporation-driven flow in 25 and 7 nm tall nanoslit channels, showing that the consequent flow speed is about 15 times slower than open atmospheric evaporation due to the confinement of the nanoslit channel. We also measured the surface acoustic wave-driven flow in the 25 nm channel, showing flow at a speed of 0.12 m/s from acoustic wave propagation at 39.7 MHz interacting with the fluid in the channel. A process to eliminate the many sources of noise to produce these results is provided, showing that─in particular─spatial averaging is useful to determine the fluid flow and the dewetting of the fluid in the nanoslit channel over time.

Astrocyte glypican 5 regulates synapse maturation and stabilization

(2025)

The maturation and stabilization of appropriate synaptic connections is a vital step in neural circuit development; however, the molecular signals underlying these processes are not fully understood. We show that astrocytes, through production of glypican 5 (GPC5), are required for maturation and refinement of synapses in the mouse cortex during the critical period. In the absence of astrocyte GPC5, thalamocortical synapses show structural immaturity, including smaller presynaptic terminals, decreased postsynaptic density area, and presence of more postsynaptic partners at multisynaptic connections. This structural immaturity is accompanied by a delay in developmental incorporation of GLUA2-containing AMPARs at intracortical synapses. The functional impact of this is that mice lacking astrocyte GPC5 exhibit increased levels of ocular dominance plasticity in adulthood. This demonstrates that astrocyte GPC5 is necessary for maturation and stabilization of synaptic connections, which has implications for disorders with altered synaptic function where GPC5 levels are altered, including Alzheimer's disease and frontotemporal dementia.

Cover page of Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.

Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.

(2025)

Although inflammation has been widely associated with cancer development, how it affects the outcomes of immunotherapy and chemotherapy remains incompletely understood. Here, we show that CKLF-like MARVEL transmembrane domain-containing member 4 (CMTM4) is highly expressed in multiple human and murine cancer types including Lewis lung carcinoma, triple-negative mammary cancer and melanoma. In lung carcinoma, loss of CMTM4 significantly reduces tumor growth and impairs NF-κB, mTOR, and PI3K/Akt pathway activation. Furthermore, we demonstrate that CMTM4 can regulate epidermal growth factor (EGF) signaling post-translationally by promoting EGFR recycling and preventing its Rab-dependent degradation. Consequently, CMTM4 knockout sensitizes human lung tumor cells to EGFR inhibitors. In addition, CMTM4 knockout tumors stimulated with EGF show a decreased ability to produce inflammatory cytokines including granulocyte colony-stimulating factor (G-CSF), leading to decreased recruitment of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) and therefore establishing a less suppressive tumor immune environment in both lung and mammary cancers. We also present evidence indicating that CMTM4-targeting siRNA-loaded liposomes reduce lung tumor growth in vivo and prolong animal survival. Knockout of CMTM4 enhances immune checkpoint blockade or chemotherapy to further reduce lung tumor growth. These data suggest that CMTM4 represents a novel target for the inhibition of tumor inflammation, and improvement of the immune response and tumor drug sensitivity.

Cover page of Outcomes of Kidney Transplantation From Donors on Renal Replacement Therapy.

Outcomes of Kidney Transplantation From Donors on Renal Replacement Therapy.

(2025)

BACKGROUND: The increasing demand for organs has pushed transplant providers to expand kidney acceptance criteria. The use of kidneys from donors with AKI has been shown to provide good long-term graft survival. We aim to evaluate and compare the outcomes of deceased donor kidney transplantation from donors with acute kidney injury (AKI), either with or without renal replacement therapy (AKI-RRT) before donation. METHODS: A single-center retrospective review of all patients who underwent deceased donor kidney transplantation from AKI donors between 2009 and 2020 was performed. AKI donors were defined on the basis of donor terminal creatinine ≥2.0 mg/dL or use of RRT before donation. We compared the outcomes of recipients receiving a kidney from a donor with AKI versus AKI-RRT. Data are presented as medians (interquartile ranges) and numbers (percentages). RESULTS: Four hundred ninety-six patients were identified, of whom 300 (60.4%) were men with a median age of 57 y at transplantation. Thirty-nine patients received an AKI-RRT, whereas 457 received an AKI kidney. Donors in the AKI-RRT group were younger (28 versus 40), had less incidence of hypertension (15.3% versus 31.9%), and were more likely to be imported (94.9% versus 76.8%). There was a higher incidence of delayed graft function (72% versus 44%, P < 0.001) in the AKI-RRT group. Recipients in both groups had similar 90-d (100% versus 95.2%) and 1-y (100% versus 91.9%) graft survival. With a median follow-up of 5 y, there was no difference in death-censored graft survival in both groups (P = 0.83). CONCLUSIONS: Careful selection of kidneys from donors with AKI on RRT can be safely used for kidney transplantation with favorable clinical outcomes.

Cover page of The Impact of Postoperative Dual Antiplatelet Therapy on Outcomes of Endovascular Therapies in Patients with Chronic-Limb Threatening Ischemia in the Vascular Quality Initiative-Medicare-Linked Database

The Impact of Postoperative Dual Antiplatelet Therapy on Outcomes of Endovascular Therapies in Patients with Chronic-Limb Threatening Ischemia in the Vascular Quality Initiative-Medicare-Linked Database

(2025)

Objectives

The beneficial effects of dual antiplatelet therapy (DAPT) compared to single antiplatelet therapy (SAPT) have been well established in coronary and carotid endovascular interventions; however, no consensus exists to the role of DAPT in lower extremity endovascular therapies (ET). We aimed to investigate the impact of postoperative DAPT following ET in patients presenting with chronic limb-threatening ischemia (CLTI) in the Vascular Quality Initiative-Medicare-Linked (Vascular Implant Surveillance and Interventional Outcomes Network [VISION]) database.

Methods

The study was a multicenter retrospective analysis of prospectively collected VQI-Medicare-Linked data. The VISION database was queried for all ETs performed for infrainguinal occlusive disease between 2011 and 2019. The patients were stratified by discharge antiplatelet regimen (DAPT vs. SAPT). SAPT patients received either aspirin or P2Y12 inhibitors whereas DAPT patients received both. The primary outcome was 1- and 5-year amputation-free survival (AFS). The secondary outcomes included 1- and 5-year overall survival, limb salvage (freedom from major amputation), and freedom from reintervention. Kaplan-Meier survival estimates and Cox regression were used for analysis.

Results

The study included two cohorts: SAPT (N=10,086, 41.7%) and DAPT (N=14,081, 58.3%). The patients in SAPT cohort were older than their DAPT counterparts and were more likely to have congestive heart failure and chronic kidney disease. While the patients in the DAPT cohort were more likely to have diabetes and coronary artery disease. In survival analyses, compared to SAPT, 1-year AFS in the DAPT cohort was 67.9% vs. 63.7% (P<.001) and 5- year AFS was 30.4% vs. 24.6% (P<.001). After adjusting for potential confounders, DAPT was associated with reduced hazards of major amputation or death at 1-year (adjusted hazard ratio [aHR]=0.82; 95% confidence interval [CI], 0.75-0.89; P<.001) and 5-year (aHR=0.91; 95% CI, 0.84-0.99; P=0.027). DAPT was also associated with lesser hazards of death (aHR=0.90; 95% CI, 0.81-0.99; P=0.048) and major amputation (aHR=0.86; 95% CI, 0.79-0.93; P<.001) at 1-year but not 5-year. Reintervention was not impacted by the antiplatelet therapy strategy. In our sub-analysis, we found superior five-year overall and amputation-free survivals in patients receiving DAPT compared to aspirin alone and also in patients receiving P2Y12 inhibitor alone compared to aspirin alone. However, the outcomes of DAPT vs. P2Y12 inhibitor alone were not significantly different.

Conclusions

In this large Medicare-linked national analysis, we found that DAPT is associated with improved AFS up to five years following ET in patients with CLTI compared to SAPT. However, there was no difference between DAPT and P2Y12 inhibitor alone. Additionally, P2Y12 inhibitor was associated with improved AFS up to five years compared to aspirin. Our findings support the use of DAPT or P2Y12 inhibitor following ETs performed in the lower extremity for CLTI; however, further prospective studies are required to confirm our findings.

Cover page of CDK1-loaded extracellular vesicles promote cell cycle to reverse impaired wound healing in diabetic obese mice

CDK1-loaded extracellular vesicles promote cell cycle to reverse impaired wound healing in diabetic obese mice

(2025)

Small extracellular vesicles (sEVs) mediate intercellular signaling to coordinate the proliferation of cell types that promote re-epithelialization of skin following injury. Cyclin-dependent kinase 1 (CDK1) drives cell division and is a key regulator of entry to the cell cycle. To understand the potential of sEV-mediated delivery of CDK1 to reverse impaired wound healing, we generated CDK1-loaded sEVs (CDK1-sEVs) and evaluated their ability to mediate cell proliferation, re-epithelialization, and downstream signaling responses in the wound bed. We found that treatment of human keratinocytes with CDK1-sEVs increased phosphorylation of the CDK1 target, eukaryotic translation inhibition factor 4E-binding protein 1 (4E-BP1), and histone H3 within 24 h via AKT and ERK phosphorylation, driving increased proliferation and cell migration. Treatment of the wound bed of diabetic obese mice, a model of delayed wound healing, with a single dose of CDK1-sEVs accelerated wound closure, increased re-epithelialization, and promoted the proliferation of keratinocytes. These studies show that delivery of CDK1 by sEVs can stimulate selective and transient proliferation of cell types that increase re-epithelialization and promote proliferation of keratinocytes to accelerate wound healing.

Cover page of Mitochondria- and ER-associated actin are required for mitochondrial fusion.

Mitochondria- and ER-associated actin are required for mitochondrial fusion.

(2025)

Mitochondria are crucial for cellular metabolism and signalling. Mitochondrial activity is modulated by mitochondrial fission and fusion, which are required to properly balance metabolic functions, transfer material between mitochondria, and remove defective mitochondria. Mitochondrial fission occurs at mitochondria-endoplasmic reticulum (ER) contact sites, and requires the formation of actin filaments that drive mitochondrial constriction and the recruitment of the fission protein DRP1. The role of actin in mitochondrial fusion remains entirely unexplored. Here we show that preventing actin polymerisation on either mitochondria or the ER disrupts both fission and fusion. We show that fusion but not fission is dependent on Arp2/3, whereas both fission and fusion require INF2 formin-dependent actin polymerization. We also show that mitochondria-associated actin marks fusion sites prior to the fusion protein MFN2. Together, our work introduces a method for perturbing organelle-associated actin and demonstrates a previously unknown role for actin in mitochondrial fusion.